Magic mushroom therapy meets CBT in new depression trial
NCT ID NCT07281352
First seen Jan 10, 2026 · Last updated May 23, 2026 · Updated 19 times
Summary
This study combines psilocybin (the active ingredient in magic mushrooms) with cognitive behavioral therapy (CBT) to treat depression. Researchers want to see if this approach is practical and helpful for 50 adults aged 21-60 with major depression. Participants will receive two doses of psilocybin and either 12 sessions of CBT or 6 sessions of standard support.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DIORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UCLA Semel Institute
RECRUITINGLos Angeles, California, 90095, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.